arrow
K

Kimberly A. Foster

Bristol Myers Squibb
H指数:26
被引数:2,970
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Utilizing Flux to Inform Formulation Strategy Decisions in Preclinical Studies

利用通量信息指导临床前研究中的配方策略决策

2026-01-010
PRE
Hydrolysis of cellulose acetate phthalate and hydroxypropyl methylcellulose phthalate in amorphous solid dispersions
2025-01-010
PRE
Hexadecanoic acid mediated cell cycle arrest involving inhibition of cell migration
2024-03-220
PRE
Discovery of 12 (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic Disorders
2023-09-191
PRE
Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activities
2023-05-011
PRE
Enhanced aqueous dissolution of hydrophobic apixaban via direct incorporation of hydrophilic nanographene oxide
2022-08-015
PRE
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders
2021-10-068
PREAI
Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors

构象分析指导的2,3-二取代吡啶IDO1抑制剂的发现

2021-06-162
OAAI
Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo Exploration
2021-04-204
PREAI
Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate
2021-03-312
OAAI
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1

BMS-986242的发现和临床前评估,一种有效的,选择性的Indoleamine-2,3-双加氧酶1抑制剂

2021-01-2820
OA
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia
2020-08-2453
OA
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists
2018-01-2724
PREAI
ABRUPT CLINICAL ONSET OF CHIARI MALFORMATION TYPE 1 FOLLOWING MINOR TRAUMA IN A PEDIATRIC PATIENT
2018-01-010
PREAI
SURGICAL DECOMPRESSION OF CHIARI II MALFORMATION IN EARLY INFANCY FOR SEVERE SLEEP APNEA
2018-01-010
PREAI
Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance
2018-01-0161
OAAI
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT2C Receptor Agonists
2017-07-0714
PREAI
A Novel Regulatory Cascade Involving BluR, YcgZ, and Lon Controls the Expression of Escherichia coli OmpF Porin
2017-06-308
OAAI
Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode
2017-02-0925
PREAI
Inhibition of PI3K/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in established and primary cultured glioblastoma cells
2014-10-010
PRE